Literature DB >> 24774589

Resistant hypertension: demography and clinical characteristics in 6,292 patients in a primary health care setting.

Teresa Gijón-Conde1, Auxiliadora Graciani2, José R Banegas2.   

Abstract

INTRODUCTION AND
OBJECTIVES: The prevalence of resistant hypertension has recently been reported, but there are no studies on its demography. This study aimed to examine the demography and clinical characteristics of resistant hypertension in a large sample of primary care patients.
METHODS: A cross-sectional study was performed of all computerized medical records of hypertensive patients in Health Area 6 of Madrid (Spain). Of 63 167 hypertensive patients, we selected 48 744 with prescription of antihypertensive medication; of these, we selected those who met the American Heart Association criteria for resistant hypertension.
RESULTS: A total of 6292 patients had resistant hypertension, representing 9.9% of all hypertensive patients and 12.9% of those treated. A total of 5.5% were < 50 years (8.5% men and 3.2% women) and 24.7% were > 80 years (15.8% men and 31.4% women) (P < .001). In patients < 50 years, resistant hypertension was associated with male sex (odds ratio female/male = 0.006; 95% confidence interval, 0.000-0.042; P < .001), systolic blood pressure, obesity, stroke, and chronic kidney disease (P < .001). In those > 80 years, resistant hypertension was associated with female sex (odds ratio female/male = 1.27; 95% confidence interval, 1.08-1,10; P = .004), systolic blood pressure, diabetes mellitus, obesity, chronic kidney disease, coronary heart disease, and atrial fibrillation (P < .001). More than 50% of patients > 80 years with resistant hypertension had cardiovascular disease.
CONCLUSIONS: One in 4 patients with resistant hypertension is > 80 years. Resistant hypertension is associated with cardiovascular disease, age < 50 years in men and age > 80 years in women. There is a high proportion of cardiovascular disease in elderly patients with resistant hypertension.
Copyright © 2013 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Blood pressure; Epidemiology; Epidemiología; Hipertensión resistente; Presión arterial; Resistant hypertension

Mesh:

Substances:

Year:  2014        PMID: 24774589     DOI: 10.1016/j.rec.2013.09.027

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  10 in total

1.  Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study.

Authors:  Simone Romano; Chiara Idolazzi; Cristiano Fava; Luigi Fondrieschi; Mario Celebrano; Pietro Delva; Lorella Branz; Angela Donato; Andrea Dalbeni; Pietro Minuz
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-06-29

Review 2.  The Use of Precision Medicine to Manage Obstructive Sleep Apnea Treatment in Patients with Resistant Hypertension: Current Evidence and Future Directions.

Authors:  Esther Sapiña; Gerard Torres; Ferran Barbé; Manuel Sánchez-de-la-Torre
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

3.  Potential effects of age on screening for primary aldosteronism.

Authors:  Q Luo; N F Li; X G Yao; D L Zhang; S F Y Abulikemu; G J Chang; K M Zhou; G L Wang; M H Wang; W J Ouyang; Q Y Cheng; Y Jia
Journal:  J Hum Hypertens       Date:  2015-04-16       Impact factor: 3.012

Review 4.  Resistant or refractory hypertension: are they different?

Authors:  Rodrigo Modolo; Ana Paula de Faria; Aurélio Almeida; Heitor Moreno
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

Review 5.  Non-invasive Renal Denervation: Update on External Ultrasound Approaches.

Authors:  Roland E Schmieder; Christian Ott; Peter Bramlage
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

6.  Resistant hypertension: risk factors, subclinical atherosclerosis, and comorbidities among adults-the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Authors:  Paulo A Lotufo; Alexandre C Pereira; Paulo S Vasconcellos; Itamar S Santos; Jose Geraldo Mill; Isabela M Bensenor
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-23       Impact factor: 3.738

7.  Prevalence and characteristics of resistant hypertensive patients in an Asian population.

Authors:  Rabia Naseem; Arsalan Majeed Adam; Fiza Khan; Adiya Dossal; Ibrahim Khan; Ammara Khan; Hannah Paul; Hafsa Jawed; Aisha Aslam; Faez Muhammad Syed; Muhammad Ahsen Niazi; Shehzeen Nadeem; Aruba Khan; Amber Zia; Mohammad Hussham Arshad
Journal:  Indian Heart J       Date:  2017-01-26

8.  Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects.

Authors:  Patricia N Sidharta; Meggane Melchior; Martin K Kankam; Jasper Dingemanse
Journal:  Drug Des Devel Ther       Date:  2019-03-22       Impact factor: 4.162

9.  Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly.

Authors:  Jean Kaboré; Marie Metzger; Catherine Helmer; Claudine Berr; Christophe Tzourio; Ziad A Massy; Bénédicte Stengel
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.

Authors:  Esther de Beus; Nicolette G C van der Sande; Michiel L Bots; Wilko Spiering; Michiel Voskuil; Frank L J Visseren; Peter J Blankestijn
Journal:  BMJ Open       Date:  2017-09-06       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.